Table 13.6g

Immunosuppression Use for Maintenance Between Discharge

and One Year Following Transplantation, 1996 to 2005

Recipients with Heart-Lung Transplants

  Year of Transplant
1996 1997 1998 1999 2000 2001 2002 2003 2004 2005
Transplants 39 62 47 51 48 27 33 29 40 35
Tx with Follow-up Immunosuppression Info 22 34 24 28 29 21 21 13 30 25
Corticosteroids Any in Category 100.0% 100.0% 95.8% 96.4% 100.0% 95.2% 100.0% 92.3% 100.0% 100.0%
Steroids 100.0% 100.0% 95.8% 96.4% 100.0% 95.2% 100.0% 92.3% 100.0% 100.0%
Cyclosporine Any in Category 86.4% 55.9% 62.5% 53.6% 58.6% 47.6% 52.4% 38.5% 36.7% 48.0%
Sandimmmune 36.4% 5.9% 0.0% 0.0% 6.9% 0.0% 0.0% 0.0% 0.0% 0.0%
Neoral 50.0% 50.0% 62.5% 53.6% 44.8% 42.9% 47.6% 23.1% 26.7% 28.0%
Gengraf 0.0% 0.0% 0.0% 0.0% 6.9% 4.8% 4.8% 15.4% 10.0% 20.0%
Eon 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Tacrolimus Any in Category 13.6% 47.1% 37.5% 50.0% 58.6% 76.2% 66.7% 76.9% 73.3% 88.0%
Tacrolimus 13.6% 47.1% 37.5% 50.0% 58.6% 76.2% 66.7% 76.9% 73.3% 88.0%
Antimetabolites Any in Category 81.8% 88.2% 95.8% 89.3% 93.1% 95.2% 95.2% 84.6% 90.0% 100.0%
Mycophenolate Mofetil 13.6% 23.5% 54.2% 42.9% 48.3% 47.6% 38.1% 38.5% 43.3% 52.0%
Mycophenolate Sodium 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Azathioprine 68.2% 64.7% 41.7% 46.4% 44.8% 47.6% 57.1% 46.2% 46.7% 48.0%
Cytoxan 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
mTOR Inhibitors Any in Category 0.0% 0.0% 4.2% 3.6% 10.3% 0.0% 9.5% 0.0% 6.7% 8.0%
Sirolimus 0.0% 0.0% 4.2% 3.6% 10.3% 0.0% 9.5% 0.0% 6.7% 8.0%
Everolimus 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%


Source: OPTN/SRTR Data as of May 1, 2007.

Percentages are calculated based on the total number of patients with any immunosuppression use between discharge and one year following transplantation.

Individual drug percentages will not necessarily add up to the drug category percentages, as patients may be prescribed more than one drug within the same category.